Small Volatile Inhibitors Targeting LncRNA in Radioresistant Non-small Cell Lung Cancer
نویسندگان
چکیده
Background and objectivesRadiotherapy is the most crucial nonsurgical therapeutic method in multidisciplinary care of non-small cell lung cancer (NSCLC) patients. However, radiation resistance continues to be a significant clinical issue, negatively affecting prognosis The small molecules that target these RNAs offer modulation multiple biological processes. study aims identify genes long non-coding RNA (lncRNA) regulating their expression binding potential volatile inhibitors lncRNA overcome radioresistance NSCLC.
منابع مشابه
Clinicopathological Features of Patients with Non-small-cell Lung Cancer in West of Iran
Background: Lung cancer is the most common cause of cancer death worldwide with an annual mortality rate of more than 1.3 million worldwide. We aimed to analyze the clinicopathological features of patients with non-small-cell lung cancer (NSCLC) in west of Iran. Methods: 64 patients with NSCLC who referred to our clinic were analyzed. Sex, age, histopathology, location of the tumor, treatment,...
متن کاملSentinel Node Mapping in Non-small Cell Lung Cancer Using an Intraoperative Radiotracer Technique
Objective(s): Lymph node metastases are the most significant prognostic factor in localized non-small cell lung cancer (NSCLC). Identification of the first nodal drainage site (sentinel node) may improve detection of metastatic nodes. Extended surgeries, such as lobectomy or pneumonectomy with lymph node dissection, are among the therapeutic options of higher acceptab...
متن کاملMulti-target inhibitors in non-small cell lung cancer (NSCLC).
Lung cancer is the leading cause of cancer death world-wide [1]. Current treatment modalities, including chemotherapy, radiotherapy and surgery, have provided only limited improvement in the natural course of this disease. Therefore, the development of new therapeutic strategies is highly awaited [2]. In the last years, there has been an explosion in the knowledge of the genetic and biologic un...
متن کاملTargeting EIF4F complex in non-small cell lung cancer cells
Non-small cell lung cancer (NSCLC) accounts for about 85-90% of lung cancer cases, which represents the leading cause of cancer-related death in the world. The majority of lung cancer patients doesn't respond well to conventional chemo-/radio-therapeutic regimens and have a poor prognosis. The recent introduction of targeted therapy and immunotherapy gives new hopes to NSCLC patients, but their...
متن کاملTargeting Angiogenesis in Non-Small Cell Lung Cancer (NSCLC)
The management of NSCLC has undergone a paradigm shift in the last 5 years with the survival advantage demonstrated by the addition of bevacizumab to standard frontline platinum-based doublet specifically, paclitaxel and carboplatin. The increased toxicity observed in patients with squamous histology and in elderly patients treated with angiogenesis-targeting agents has led to even greater scru...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gene Expression
سال: 2023
ISSN: ['1052-2166', '1555-3884']
DOI: https://doi.org/10.14218/ge.2023.00005s